These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 26681918)

  • 1. Targeting Tumor Metabolism for Cancer Treatment: Is Pyruvate Dehydrogenase Kinases (PDKs) a Viable Anticancer Target?
    Zhang W; Zhang SL; Hu X; Tam KY
    Int J Biol Sci; 2015; 11(12):1390-400. PubMed ID: 26681918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting pyruvate dehydrogenase kinase signaling in the development of effective cancer therapy.
    Anwar S; Shamsi A; Mohammad T; Islam A; Hassan MI
    Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188568. PubMed ID: 34023419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in mechanisms regulating glucose oxidation at the level of the pyruvate dehydrogenase complex by PDKs.
    Sugden MC; Holness MJ
    Am J Physiol Endocrinol Metab; 2003 May; 284(5):E855-62. PubMed ID: 12676647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic Targeting of the Pyruvate Dehydrogenase Complex/Pyruvate Dehydrogenase Kinase (PDC/PDK) Axis in Cancer.
    Stacpoole PW
    J Natl Cancer Inst; 2017 Nov; 109(11):. PubMed ID: 29059435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in pyruvate dehydrogenase kinase inhibitors: Structures, inhibitory mechanisms and biological activities.
    Li Y; Xie Z; Lei X; Yang X; Huang S; Yuan W; Deng X; Wang Z; Tang G
    Bioorg Chem; 2024 Mar; 144():107160. PubMed ID: 38301426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Pyruvate Dehydrogenase Kinase as a Therapeutic Strategy against Cancer.
    Sradhanjali S; Reddy MM
    Curr Top Med Chem; 2018; 18(6):444-453. PubMed ID: 29788890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pyruvate dehydrogenase complex in cancer: An old metabolic gatekeeper regulated by new pathways and pharmacological agents.
    Saunier E; Benelli C; Bortoli S
    Int J Cancer; 2016 Feb; 138(4):809-17. PubMed ID: 25868605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormonal regulation of glycolytic enzyme gene and pyruvate dehydrogenase kinase/phosphatase gene transcription.
    Wang Z; Iwasaki Y; Zhao LF; Nishiyama M; Taguchi T; Tsugita M; Kambayashi M; Hashimoto K; Terada Y
    Endocr J; 2009; 56(8):1019-30. PubMed ID: 19706989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of pyruvate dehydrogenase kinase inhibitors in medicinal chemistry with particular emphasis as anticancer agents.
    Zhang SL; Hu X; Zhang W; Yao H; Tam KY
    Drug Discov Today; 2015 Sep; 20(9):1112-9. PubMed ID: 25842042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyruvate Dehydrogenase Kinases: Therapeutic Targets for Diabetes and Cancers.
    Jeoung NH
    Diabetes Metab J; 2015 Jun; 39(3):188-97. PubMed ID: 26124988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. R-lipoic acid inhibits mammalian pyruvate dehydrogenase kinase.
    Korotchkina LG; Sidhu S; Patel MS
    Free Radic Res; 2004 Oct; 38(10):1083-92. PubMed ID: 15512796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liquid Chromatography-Tandem Mass Spectrometry Method Revealed that Lung Cancer Cells Exhibited Distinct Metabolite Profiles upon the Treatment with Different Pyruvate Dehydrogenase Kinase Inhibitors.
    Zhang W; Hu X; Zhou W; Tam KY
    J Proteome Res; 2018 Sep; 17(9):3012-3021. PubMed ID: 30028142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation of (R)-3,3,3-trifluoro-2-hydroxy-2-methylpropionamides as pyruvate dehydrogenase kinase 1 (PDK1) inhibitors to reduce the growth of cancer cells.
    Zhang SL; Zhang W; Yang Z; Hu X; Tam KY
    Eur J Pharm Sci; 2017 Dec; 110():87-92. PubMed ID: 28347773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-throughput screening of novel pyruvate dehydrogenase kinases inhibitors and biological evaluation of their in vitro and in vivo antiproliferative activity.
    Wu DM; Wang YJ; Fan SH; Zhang ZF; Shan Q; Lu J; Chen GQ; Zheng YL
    Eur J Med Chem; 2019 Feb; 164():252-262. PubMed ID: 30597326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational Study on New Natural Compound Inhibitors of Pyruvate Dehydrogenase Kinases.
    Zhou X; Yu S; Su J; Sun L
    Int J Mol Sci; 2016 Mar; 17(3):340. PubMed ID: 26959013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyruvate dehydrogenase kinases (PDKs): an overview toward clinical applications.
    Wang X; Shen X; Yan Y; Li H
    Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33739396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic Flexibility in Cancer: Targeting the Pyruvate Dehydrogenase Kinase:Pyruvate Dehydrogenase Axis.
    Woolbright BL; Rajendran G; Harris RA; Taylor JA
    Mol Cancer Ther; 2019 Oct; 18(10):1673-1681. PubMed ID: 31511353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting cellular metabolism to improve cancer therapeutics.
    Zhao Y; Butler EB; Tan M
    Cell Death Dis; 2013 Mar; 4(3):e532. PubMed ID: 23470539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of dual inhibitors targeting pyruvate dehydrogenase kinases and human lactate dehydrogenase A: High-throughput virtual screening, synthesis and biological validation.
    Xiang S; Huang D; He Q; Li J; Tam KY; Zhang SL; He Y
    Eur J Med Chem; 2020 Oct; 203():112579. PubMed ID: 32688200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of novel pyruvate dehydrogenase kinases inhibitors by screening of an in-house small molecule library for anti-lung cancer therapeutics.
    Guo F; Zhao S; Li X
    Bioorg Med Chem Lett; 2019 Jan; 29(2):291-296. PubMed ID: 30470491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.